1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. WALPAR NUTRITIONS LTD.
Walpar Nutritions Ltd.
NSE: WALPAR

Walpar Nutritions Live Share Price Today, Share Analysis and Chart

aboutWalpar Nutritions Ltd. is an India-based company specializing in the manufacturing and marketing of nutraceuticals, herbal, and ayurvedic products. The company operates as a contract manufacturer and also markets its own brand, focusing on health sup... Read More
Ask AI about Walpar Nutritions
25.00-1.10(-4.21%)
2,000
NSE Volume

NSE 28 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Walpar Nutritions Stock Price Analysis

Walpar Nutritions Technical Analysis

Walpar Nutritions EMA & SMA

Bearish-8
0 bullish, 8 bearish
Bullish0
Bearish8
5 Day26.0
10 Day26.1
12 Day26.1
20 Day26.3
26 Day26.6
50 Day28.6
100 Day32.6
200 Day37.8

Walpar Nutritions Delivery And Volume

Daily Avg. Delivery Volume %
28 Oct, 2026100.0%
Week100.0%
Month-

Walpar Nutritions Active Candlesticks

Short Line Uptrend
Legend
Positive IndicatorNeutral IndicatorNegative Indicator

Walpar Nutritions Resistance and Support

25.00
Pivot
First Resistance25
Second Resistance25
Third Resistance25
First Support25
Second Support25
Third Support25
Day RSI42.7
Day MACD-0.6
Day MFI35.6
Day MACD Signal Line-0.8

Walpar Nutritions Beta

1 Month0.5
1 Year-0.3
3 Month-0.2
3 Year0.0

Walpar Nutritions Price Change Analysis

↓-8.8%
Over 1 Month
LowHigh
2529
↓-28.3%
Over 3 Months
LowHigh
21.334.9
↓-32.4%
Over 6 Months
LowHigh
21.338
↓-43.2%
Over 1 Year
LowHigh
21.350.6

Walpar Nutritions Shareholding Pattern/ Ownership

Shareholding Summary

Sep 2026
 
NameCategorySharesShares %
Kalpesh Pravinchandra LadhawalaPromoter1,724,00018.4 %
HufPublic208,0002.2 %

HISTORICAL PROMOTER HOLDING

HISTORICAL FII HOLDING

HISTORICAL MF HOLDING

Walpar Nutritions Deals - Insider, Bulk, Block and SAST

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
SHRI BAJRANGBALI ASHOK CONSTRUCTION PRIVATE LIMITEDBulkSell14 Aug 202466.0642,000NSE
TANMAYKUMAR ASHWINBHAI SHAHBulkSell12 Aug 2024130.5035,000NSE
SEJAL KALPESH LADHAWALABulkSell12 Aug 2024130.5068,000NSE
SHRI BAJRANGBALI ASHOK CONSTRUCTION PRIVATE LIMITEDBulkPurchase12 Aug 2024130.50100,000NSE
PREEYESH KHANNABulkPurchase28 May 2024129.1527,000NSE
RAJESHKUMAR JANARDAN SINGHBulkSell23 May 2024110.1426,000NSE
STATSOL RESEARCH LLPBulkSell18 Jan 2024126.7524,000NSE
STATSOL RESEARCH LLPBulkPurchase18 Jan 2024126.7524,000NSE
XTENDED BUSINESS REPORTING LIMITEDBulkSell22 Aug 2022558,000NSE
XTENDED BUSINESS REPORTING LIMITEDBulkPurchase22 Aug 202255.8630,000NSE

Walpar Nutritions Corporate Actions

Walpar Nutritions Bonus shares

Walpar Nutritions bonus history along with announcement, record, ex-bonus dates, and bonus ratios.

#Ex-Date
Bonus RatioRecord Date
114 Aug 2024
1:114 Aug 2024

Walpar Nutritions Board Meetings

Walpar Nutritions past and upcoming board meetings.

#Ex-Date
PurposeNotes
105 Nov 2026
Quarterly Results and Other business matters-
228 May 2026
Audited Results-
315 May 2025
Audited Results-
412 Nov 2024
Quarterly Results-
505 Jul 2024
Bonus issue-

Walpar Nutritions - Company Profile

Walpar Nutritions Management Structure

Walpar Nutritions management structure with salaries, total experience, and qualifications.

NAMEDESIGNATIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Rahi Anilbhai ThakkarCompany Secretary-Mar 26
Sejal LadhawalaExecutive Director,Chief Financial Officer-Mar 26

Walpar Nutritions Board of Directors

Walpar Nutritions Board of directors with salaries, total experience, and qualifications.

NAMEPOSITIONGROSS REMUNERATION ₹(LAC)AS OFHISTORY & DETAILS
Kalpesh Pravinchandra LadhawalaManaging Director-Mar 25
Sejal LadhawalaExecutive Director & CFO-Mar 25
Tanmaykumar Ashwinbhai ShahWhole-time Director-Mar 25
Krunal Jashubhai PatelExecutive Director-Mar 25
Nidhi YogeshKumar ShahExecutive Director-Mar 25
Abhishekkumar Dineshkumar PatelExecutive Director-Mar 25
Fenil Prakashkumar ShaExecutive Director-Mar 25
Jigneshkumar Dineshkumar ModiExecutive Director-Mar 25
Jayshukh Ramjibhai DetrojaIndependent Director-Mar 25
Tapan Natverlal PatelIndependent Director-Mar 25
Nehalkumar Jasvantlal ShahIndependent Director-Mar 25
Rupesh Himatla ShahIndependent Director-Mar 25
Rahi Anilbhai ThakkarCompany Sec. & Compli. Officer-Mar 25

About the company - Business Profile

Walpar Nutritions Ltd. is an India-based company specializing in the manufacturing and marketing of nutraceuticals, herbal, and ayurvedic products. The company operates as a contract manufacturer and also markets its own brand, focusing on health supplements and wellness products. It serves various therapeutic areas, including immunity boosters, health supplements, and lifestyle-related wellness segments.

Key Points

  • Key Facts:
    • Founded Year: 2009.
    • Headquarters: Gandhinagar, Gujarat, India.
    • Stock Listing: Listed on the NSE SME platform (Stock Code: WALPAR).
    • Core Products: Tablets, capsules, syrups, and powders across Nutraceutical, Ayurvedic, and Herbal categories.
  • Operations and Resources:
    • The company operates a manufacturing facility in Gandhinagar, Gujarat.
    • The facility is equipped to handle multiple dosage forms, including solid orals (tablets/capsules) and liquid orals (syrups/suspensions).
  • Market and Significance:
    • Walpar Nutritions serves the growing preventive healthcare and wellness market in India.
    • It acts as a key partner for third-party brands through its contract manufacturing services, providing end-to-end solutions from formulation to packaging.
  • Business Model:
    • The company follows a dual business model: Contract Manufacturing (B2B) for other pharmaceutical and nutraceutical companies and Own Brand Marketing (B2C) under its own labels.
    • It focuses on high-growth segments like sports nutrition, pediatric supplements, and general wellness.
  • Financial Performance (FY2024-25):
    • (Note: Specific segment-wise revenue splits for FY25 were not explicitly detailed in the provided search results; however, general financial trends for similar companies in the sector indicate steady growth in the domestic nutraceutical space.)
    • Historically, the company has derived a significant portion of its revenue from the domestic Indian market through both institutional sales and retail distribution.
  • Key Products and Technology:
    • Product range includes Vitamin and Mineral supplements, Protein powders, and specialized Ayurvedic formulations for joint care, liver health, and immunity.
    • The company utilizes standardized herbal extracts to ensure consistency in its ayurvedic and herbal product lines.
  • Employee Count and Attrition:
    • The company maintains a workforce comprising production staff, quality control experts, and a dedicated sales team. (Specific headcount figures for FY25 are not available in the summary documents).
  • Strategic Initiatives and Outlook:
    • Expanding the direct-to-consumer (D2C) presence through e-commerce platforms.
    • Increasing the manufacturing capacity to accommodate higher volumes of third-party contract manufacturing orders.
    • Exploring opportunities for exporting products to emerging markets with high demand for herbal and natural supplements.

References

  1. Annual Report May 2025
  2. Annual Report May 2025
  3. Investor Presentation Feb 2026

Walpar Nutritions FAQ

Walpar Nutritions today is trading in the red, down by 4.21% at ₹25.
Walpar Nutritions is currently trading down 4.21% on an intraday basis. In the past week the stock fell 4.21%. Stock has been down 28.26% in the past quarter and fell 43.18% in the past year. You can view this in the share price history/seasonality section.
Walpar Nutritions is listed on NSE with the ticker WALPAR. It's currently trading on NSE at a share price of ₹25.
The market cap of Walpar Nutritions is ₹23.48 Cr. as of Oct 28, 2026.
Walpar Nutritions has never announced any dividend since the time of its listing on the NSE exchange.
Walpar Nutritions has never issued stock splits, but it has issued 1 bonus shares since its NSE listing. The latest announcement for Walpar Nutritions bonus shares was on Aug 14, 2024 at a ratio of 1:1.
Walpar Nutritions reported ₹79.05 Cr. in revenue, ₹3 Cr. in net profit, and ₹6.92 Cr. in EBITD as of Mar 31, 2026 for FY25-26.
There are no analyst predictions for stock price target for Walpar Nutritions.
The PE ratio of Walpar Nutritions is 7.82 as of Oct 28, 2026.
The PB ratio of Walpar Nutritions is 1.24 as of Oct 28, 2026.
There are no analyst reports for Walpar Nutritions.
You can set real-time stock alerts on price, volume, SMA, and several other parameters by scrolling to the top of this page and clicking the bell icon on the far right-hand side of the stock overview.